A potential review of its traditional uses, Phytochemistry, pharmacology, and toxicity of Plumbago zeylanica

Abstract

The primary source of efficient traditional medications for the treatment of many ailments is medicinal plants. Several pharmacological actions of herbal medicines have led to their usage throughout the past ten years. The useful medical plant Plumbago zeylanica, often known as Plumbago, "white leadwort," "Ceylon leadwort," "Doctorbush," "Chitrak" in India, is used extensively in Africa and Asia to cure various maladies. It belongs to the plumbaginaceae family. The family plumbaginaceae are divided into the plumbaginoideae and staticoideae subfamilies, which may be distinguished by morphological, chemical, and molecular traits. It is a significant medicinal plant with a variety of pharmacological activities, including anticancer, antibacterial, antioxidant, etc. Because of the plant's therapeutic value, pharmaceutical companies randomly sample the environment and there is a decline in Plumbago zeylanica population, making it an over-exploited plant. Therefore, a different method of mass propagating this plant is required. It is a powerful bioactive substance with a lot of promise for use in traditional medical procedures for the treatment of many different ailments. Although it is a crucial plant in the production of herbal products, finding a different method to allow for the widespread propagation of this plant still requires a great commitment. For the expanding needs of Plumbago zeylanica, by in-vitro technologies at a large scale for progress and subsequent crushed plants should be tremendously helpful. The purpose of this review is to focus the value of medicinal applications, Phytochemistry, pharmacology, toxicity, and its prospective pharmaceutical action for the creation of novel herbal preparations. It has given researchers the chance to do further study and development in this area.